Halozyme Therapeutics, Inc. (HALO)
71.37
-0.16
(-0.22%)
USD |
NASDAQ |
Jun 08, 14:53
Halozyme Therapeutics Price : 71.37 for June 8, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vertex Pharmaceuticals, Inc. | 443.84 |
| Agenus, Inc. | 3.16 |
| Altimmune, Inc. | 2.715 |
| Lineage Cell Therapeutics, Inc. | 1.205 |
| Amgen, Inc. | 345.16 |
Price Related Metrics
| PE Ratio | 25.67 |
| PS Ratio | 5.761 |
| Price to Book Value | 38.51 |
| Price to Free Cash Flow | 13.02 |
| Earnings Yield | 3.90% |
| Market Cap | 8.459B |
| Operating PE Ratio | 10.11 |
| Normalized PE Ratio | 14.63 |